Skip to main content
Caplight Logo









TheraPanacea

TheraPanacea

Private
ParisHealthcare & Life Scienceshttps://therapanacea.com/

Last Round

Convertible Debt

Dec 14, 2021

Total Funding Raised

$17.74M

Company Overview

TheraPanacea is a medical technology company that develops AI-powered software solutions for radiotherapy and precision cancer care.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncologymedical AItreatment planningautomated segmentationsoftware as a medical deviceSaMDradiotherapyclinical workflowmedical imagingcontouringclinical decision supportAI-powered healthcarehealth-techmedtechworkflow automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TheraPanacea Comparables

Compare TheraPanacea with similar companies based on industry and business-model similarity.

TheraPanacea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MVision AI
93%
Oncosoft
89%
Vysioneer
89%

TheraPanacea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtDec 14, 2021
GrantDec 7, 2020
GrantSep 27, 2019
VC RoundFeb 22, 2019

Key People

Founding team and executive leadership

Catherine Martineau-Huynh

Chief Operating Officer & co-founder

Founding Team

Nikos Paragios

President Chief Executive Officer

Executive Team

TheraPanacea Investors

Notable investors and investment history

TheraPanacea investors
InvestorRounds
European Innovation Council FundGrant
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 14, 2021

    $15M round led by Biogen

  • Feb 22, 2019

    Raised $4M in a venture capital round.

TheraPanacea Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TheraPanacea Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TheraPanacea's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range74
Year Founded2017
Last FundingDec 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?